Hos børn, hvis mødre har taget nukleosid og nukleosidanaloger under graviditeten, er gavnen af den nedsatte chance for at være smittet med hiv større end risikoen for at få bivirkninger.
In children whose mother took nucleoside and nucleotide analogues during pregnancy, the benefit from the reduced chance of being infected with HIV is greater than the risk of suffering from side effects.